Melanoma Evidence & Self-Care · education / decision-support

← Evidence library

BIB_060

Khattak A, Weber JS, Meniawy T, et al. Distant Metastasis-Free Survival Results from KEYNOTE-942 Phase 2 mRNA-4157-P201 Trial. J Clin Oncol 2024. mRNA-4157/V940 personalised neoantigen vaccine. [Tasks: L, 17] Tier: 2 Grade: B Retrieved: 2026-05-06

Evidence grade
B
Tier
2
Cited by tasks
L, 17
Identifiers

Full extracted findings & patient-implication analysis: bibliography/BIB_060/findings.md (research corpus). This page is a short context summary — not individualised medical advice.